Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Clinical Oncology

Outcomes of liver transplant recipients with pretransplant malignancies: Insights from a single institution’s experience.

View Full Paper
Ask AI
Bookmark
Share

Authors

NVNikitha VobugariKHKirk HeyneACAshton A. Connor

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Vobugari et al. (2024) studied this question.

synapsesocial.com/papers/68e67050b6db6435875fa5cchttps://doi.org/10.1200/jco.2024.42.16_suppl.11173
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cumulative Risk Assessment for De Novo and Recurrent Nonliver Cancer After Liver Transplantation Based on Pretransplant Cancer Experience2025
  2. 2Rethinking the impact of pretransplant malignancy on eligibility for double lung transplantation (DLT): An analysis of 23,291 recipients.2024
  3. 3The Spectrum of De Novo Malignancies After Liver Transplantation: A Review on Current Trends and Surveillance2025
  4. 4Rethinking the Impact of Pretransplant Malignancy (Pre-TM) on Double Lung Transplantation (DLT) Eligibility: An Analysis of 23,291 DLT Recipients2024
  5. 5Pre-transplant hepatocellular carcinoma is associated with increased risk of post-transplant non-HCC cancer in liver transplant recipients.2026